Meaningful Revenues Being Generated by Skyrocketing Popularity of CBD Infused Products and Beverages - Seite 2

The Company also announced that, as of the start of trading today, shares of its common stock have ceased trading on the OTCQB and will be listed on the NASDAQ Capital Market (NASDAQ) under the ticker symbol "WTER." The Alkaline Water Company will retain its listing on the TSX Venture Exchange (TSXV), also under the ticker symbol "WTER."

The Company fully intends to comply with all federal, state, and local laws, rules and regulations as the Company develops its hemp infused alkaline water and other nutraceutical product lines. The Company will not pursue the production or sale of hemp infused products until legally permitted and all necessary approvals have been obtained. Read this and more news for Alkaline Water Company at:http://www.financialnewsmedia.com/news-wter/

In other industry developments in the markets:  

New Age Beverages Corporation (NASDAQ:NBEV) last week announced the signing of a definitive agreement to acquire Morinda Holdings, Inc., a Utah-based healthy lifestyles and beverage company with operations in more than 60 countries around the world. The newly combined global company will be headquartered in Denver, Colorado with major operations in Shanghai, Tokyo, Munich, Utah, and more than 20 other countries, and further strengthens New Age with the infrastructure to expand its portfolio of healthy beverages worldwide. Consideration for the transaction will be $85 million, comprised of $75 million in cash and $10 million in New Age restricted stock based on the 40-day volume-weighted average price from closing. The cash consideration for the transaction will be sourced from New Age's current cash balance. The transaction is expected to close in late December. At closing Morinda will be bringing a minimum of $25 million in working capital and no debt. Additional contingent consideration may be made to Morinda owners based on EBITDA performance in 2019.  

Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) announced late last week it has entered into a subscription agreement with Altria Group, Inc. (MO) pursuant to which Altria has agreed to make an approximately C$2.4 billion equity investment in Cronos Group on a private placement basis in exchange for common shares in the capital of the Company. Altria will also receive Warrants of Cronos Group, that if fully exercised, would provide the Company with an additional approximately C$1.4 billion of proceeds. The Shares issuable to Altria pursuant to the Subscription Agreement will result in Altria holding an approximately 45% ownership interest in Cronos Group (calculated on a non-diluted basis), exercise of the Warrants would result in incremental ownership of 10% for a total potential ownership position of 55%. This strategic partnership provides Cronos Group with additional financial resources, product development and commercialization capabilities, and deep regulatory expertise to better position the Company to compete, scale and lead the rapidly growing global cannabis industry.